Loading Events

« All Events

Dermatologic and Ophthalmic Drugs Advisory Committee

December 13

The committee will discuss biologics license application (BLA) 761143, teprotumumab solution for intravenous use, submitted by Horizon Pharma Ireland, Ltd., proposed for the treatment of active thyroid eye disease.

Details

Date:
December 13
Event Category: